Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter

Schnell, Oliver; Klausmann, G.; Gutschek, Bettina; Garcia-Verdugo, Rosa; Hummel, Michael

doi:10.1177/1932296817706376

Cited by 17 publications

(35 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The app may also save the medical record for monitoring and making decision about their diabetes management (Petersen & Hempler, 2017). In addition, as monitoring blood glucose is important for diabetes management (Claude Mbanya, Aschner, Chan, Jose Gagliardino, & Saji, 2017), using colour indicating self‐monitor blood glucose handset may also be useful as it provides a quick interpretation of the blood test results and may indirectly improve their blood glucose control (Oliver, Gerd, Bettina, Rosa Maria, & Michael, 2017). …”

Section: Discussionmentioning

confidence: 99%

Factors associated with self‐management among Vietnamese adults with type 2 diabetes

et al. 2018

View full text Add to dashboard Cite

AimThe study described diabetes self‐management (DSM), diabetes knowledge, family and friends’ support, healthcare providers’ support, belief in treatment effectiveness and diabetes management self‐efficacy, and explored DSM's associations among Vietnamese adults with type 2 diabetes mellitus (T2DM).DesignA cross‐sectional design was applied.MethodsThe study used self‐report questionnaires to collect data from 198 participants. Descriptive statistics and structural equation modelling (SEM) was used for data analysis.ResultsVietnamese adults with T2DM performed DSM limitedly in certain aspects. They had strong belief in treatment effectiveness, good family and friends support, limited diabetes knowledge, healthcare professional support and self‐efficacy. Their DSM was directly associated with diabetes knowledge, family and friends’ support, healthcare providers’ support, belief in treatment effectiveness and diabetes management self‐efficacy. Their DSM was indirectly associated with diabetes knowledge and family and friends’ support through their belief in treatment effectiveness and diabetes management self‐efficacy.

show abstract

Section: Discussionmentioning

confidence: 99%

Factors associated with self‐management among Vietnamese adults with type 2 diabetes

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Certainly, enhancement in treatment satisfaction may play a critical role in increasing patient self-efficacy and commitment to therapy, thereby supporting in reaching long-term stable glycemic control, in addition to the minimization of the risk of diabetic complications [18]. More recently, diabetes technology has extended, and studies reported that technological improvements in glucometers are enhanced diabetes management and patient satisfaction [19,[23][24][25]. In this present study, we explored whether the smartLIGHT™ based BGM can impact the clinical characteristics and GMS in T2D patients over a period of time.…”

Section: Discussionmentioning

confidence: 99%

“…It is well demonstrated that diabetes technology has expanded. Studies reported that technological improvements in glucometers, including SmartLIGHT™ glucometers, improve diabetes management and patient satisfaction due to on-screen glucose range information using a color range indicator [6,19,[23][24][25]27]. Studies also reported that a blood glucose meter that provides automatic on-screen glucose range information using a color range indicator significantly improved the ability of patients having T2D to classify blood glucose readings into low range, in the range, or high glycemic range [6].…”

Section: Discussionmentioning

confidence: 99%

Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study

Hayek¹,

Robert²,

Dawish³

2020

Cureus

View full text Add to dashboard Cite

Introduction Self-monitoring of blood glucose (SMBG) plays an important role in diabetes management. The Contour ® Next One glucometer is a recent glucometer that delivers blood glucose results by an immediate color indicator to aware users when blood glucose is at a critical high or low. The main purpose of the study was to assess the impact of an application of a blood glucose meter (BGM) having a color range indicator on clinical characteristics and glucose monitoring satisfaction (GMS) among patients having type 2 diabetes (T2D). Methods A total of 85 (male 42 and female 43) patients with T2D were switched to a BGM having smartLIGHT™ target range indicator (blood glucose meters featuring color range indicator) using Contour ® Next One glucometer. Demographic data, as well as glycemic control, were collected at baseline and 12 weeks. At the time of the baseline and 12 weeks of the study, a trained interviewer gave the GMS survey questionnaire to every patient in order to collect the glucose monitoring satisfaction. In addition to GMS, a patient's perceptions of smartLIGHT™ feature satisfaction survey responses were also collected from the patients at the end of the study (12 weeks). Results Compared to baseline, a significant improvement was observed in the subdomains of glucose monitoring satisfaction survey (GMSS) score on openness (p=0.0001), emotional burden (p=0.0001), behavioral burden (p=0.0001), and trust (p=0.0001) at the end of the study. Overall, the total GMS score at baseline was 2.61 ± 0.51, which improved up to 3.16 ± 0.63 (p=0.0001) during the period of 12 weeks. The patient satisfaction with smartLIGHT™ survey outcomes exposed evidence of satisfaction among the study population at the end of the study. There were statistically insignificant reductions observed in glycosylated hemoglobin (HbA1c) (p=0.063) and the frequency of hypoglycemia (p=0.057) at the end of the study. Conclusions The study demonstrates a significant improvement in the subdomains of GMSS-openness, emotional burden, behavioral burden, and trust-at 12 weeks than at the baseline, with the increased total GMSS score. Similarly, high satisfaction with the color-based smartLIGHT™ feature was also observed at the end of the study.

show abstract

“…The cost-effectiveness analysis was based on a previously published economic model 14,15,17 and adapted as follows:…”

Section: Methodsmentioning

confidence: 99%

“…Although the data were included based on existing studies an regional reports the analysis has limitations: the RCT by Grady et al had a relatively small sample size 11 and values for blood pressure and lipid levels were retrieved from another study population investigating GM with CRI. 17 This analysis is limited to health care system perspective excluding societal perspective.…”

Section: Limitationsmentioning

confidence: 99%

Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management

Fritzen¹,

Basinska

Rubio-Almanza

et al. 2019

J Diabetes Sci Technol

Self Cite

View full text Add to dashboard Cite

Background: Self-monitoring of blood glucose supported by the diabetes-app OneTouch Reveal® has demonstrated to improve HbA1c. We aimed at analyzing costs savings related the integration of telemedical features into diabetes management. Methods: Data from a randomized controlled trial were used to assess the 10-year risk of patients for fatal myocardial infarction (MI). On the basis of this risk assessments—also related to a 5% or 10% reduction of hypoglycemic episodes—cost savings for the health care systems of five European countries—France, Germany, Italy, Spain, and the United Kingdom—were modeled. Results: HbA1c reduction of 0.92% in insulin-treated type 2 diabetes patients (T2DM) was associated with a 2.3% decreased 10-year risk for fatal MI. In combination with a 10% reduction of hypoglycemic events this risk reduction led to cost savings of €16.1 million (France), €57.8 million (Germany), €30.9 million (Italy), €23.8 million (Spain), and €5.8 million (UK), considering all insulin-treated T2DM patients in the respective countries. Conclusion: Improving metabolic control and thus risk for comorbidities like MI by combining the glucose meter with CRI with telemedical features has the potential to reduce costs for European health care systems.

show abstract

Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter

Abstract: This real-world study demonstrates that SMBG implemented via this new blood glucose meter not only leads to an improvement in metabolic control, but also is associated with a significant improvement in diabetes management.

Cited by 17 publications

References 29 publications

Factors associated with self‐management among Vietnamese adults with type 2 diabetes

Factors associated with self‐management among Vietnamese adults with type 2 diabetes

Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study

Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management

Contact Info

Product

Resources

About